| Symbol
| MEIS2
| contributors: mct/npt - updated : 05-02-2019
|
| HGNC name
| Meis homeobox 2
|
| HGNC id
| 7001
|
| Other morbid association(s)
|
| Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
|---|
| tumoral
|
|
| --over
|
| |
extensively expressed in ovarian carcinomas and may play a role in ovarian carcinogenesis (Crijns 2007) | | constitutional
|
|
| --over
|
|
is a molecular mechanism for high expression of mitotic genes that is frequently observed in cancers of poor prognosis  | |
Variant & Polymorphism
| 
| |
| Candidate gene
| for cleft palate and heart defect |
|
combinatorial expression of Meis family proteins might be a candidate mechanism for the differential regulation of eye growth among vertebrate species (Heine 2008) |
|
suitable marker for the study of amacrine cell diversity and development in addition to providing evidence for the stepwise specification of the glycinergic and GABAergic neurotransmitter phenotypes during amacrine cell differentiation (Bumsted-O'Brien 2007) |
Marker
Therapy target
|
| | |